Skip to main content

MoneyWorks4Me

Emcure Pharmaceuticals informs about investor presentation

03 Nov 2026 Evaluate
Emcure Pharmaceuticals has enclosed the presentation on the Unaudited Financial Results for the quarter and half year ended September 30, 2026. The same is also available on the Company’s website i.e., www.emcure.com.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..